Galectin-9 (Gal-9) is a tandem-repeat galectin with diverse roles in immune homeostasis,
inflammation, malignancy, and autoimmune diseases. In cancer, Gal-9 displays variable …

Development of cancer therapeutics has traditionally focused on targeting driver oncogenes.
Such an approach is limited by toxicity to normal tissues and treatment resistance. A class of …

Simple Summary This study aims to understand the role of galectins by breast cancer
subtype and their change in response to cancer treatment. Galectins are proteins involved in …

Optimizations are expected in the development of immunotherapy for the treatment of Triple‐
negative breast cancer (TNBC). We studied the expression of galectin‐9 (Gal‐9) after …

Breast cancer has the highest global incidence and mortality rates among all cancer types.
Abnormal expression of the Annexin family has been observed in different malignant tumors …

Galectin-9 (Gal-9) is a vital member of the galectin family, functioning as a multi-subtype
galactose lectin with diverse biological roles. Recent research has revealed that Gal-9's …

The glycocalyx—that forms a protective barrier around cells—has been implicated in cancer
cell proliferation, survival, and metastasis. However, its role in maintaining the integrity of …

Cancer cells recruit neutrophils from the bloodstream into the tumor tissue, where these
immune cells promote the progression of numerous solid tumors. Studies in mice suggest …

Renal cell cancer is the most common type of kidney cancer in adults, and clear cell renal
cell carcinoma (ccRCC) is the most diagnosed type. T cell immunoglobulin and mucin …

Abstract Background Hydrogen sulfide (H2S) is a significant endogenous mediator that has
been implicated in the progression of various forms of cancer including breast cancer (BC) …